Mar 20 |
Does Celldex (CLDX) Have the Potential to Rally 71.82% as Wall Street Analysts Expect?
|
Mar 8 |
Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
|
Mar 5 |
Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
|
Mar 5 |
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
Mar 1 |
Celldex prices $400.4M stock offering
|
Mar 1 |
Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock
|
Feb 29 |
Celldex (CLDX) Upgraded to Buy: What Does It Mean for the Stock?
|
Feb 29 |
Wall Street Analysts Predict a 26.53% Upside in Celldex (CLDX): Here's What You Should Know
|
Feb 28 |
Celldex Therapeutics announces proposed public offering of shares
|
Feb 27 |
Celldex Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|